ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Zymeworks Biopharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Zymeworks Biopharmaceuticals INC. (Zymeworks Biopharmaceuticals 401(k) Plan · EIN 47-2569713 · PN 001): $12.21M net assets, 76 active participants, and $72.98 per $10,000 (72.98 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorZymeworks Biopharmaceuticals INC.
Filing IdentifierZymeworks Biopharmaceuticals 401(k) Plan · EIN 47-2569713 · PN 001
Plan Category & State401(k) Defined Contribution (US)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$12.21M
Active Participants76
Direct Admin Fee Rate$72.98 per $10,000 (72.98 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI